CLS003

DRUG3 trials

Sponsors

Maruho Co., Ltd.

Conditions

Cutaneous WartsHPV-Induced Genital Lesions

Phase 1

First-in-Human Study of CLS003 ICVT in Subjects With Cutaneous Warts

CompletedNCT02106260

Maruho Co., Ltd.Cutaneous Warts

Start: 2014-03-31Updated: 2014-05-23

Phase 2

A Phase 2 Efficacy Study of CLS003 ICVT in Subjects With Cutaneous Warts.

CompletedNCT02333643

Maruho Co., Ltd.Cutaneous Warts

Start: 2015-01-31End: 2015-08-31Updated: 2016-07-28

ICVT in HPV-induced Genital Lesions of Immunocompromised and Immunocompetent Patients

TerminatedNCT03334240

Maruho Co., Ltd.HPV-Induced Genital Lesions

Start: 2017-10-05End: 2018-10-30Updated: 2019-03-20

Related Papers

A randomized controlled proof-of-concept trial of digoxin and furosemide in adults with cutaneous warts.

2019-03-0719 citations